OmniActive Health Technologies will be presenting two highly anticipated speaking sessions during Hi Europe 2016, both on Tuesday 29 November at the Mintel Global Speaking Theatre
The first session, The Macular Carotenoids and High Energy Blue Light, which runs from 13:30-13:55, will discuss high-energy blue light, its sources and ways to help support healthy vision from its effects with lutein and zeaxanthin isomers (RR- and RS (meso)-zeaxanthin).
Attendees will also be provided with a review of new clinical results from a number of studies testing supplementation of Lutemax 2020 Lutein with Enhanced Levels of Zeaxanthin Isomers, including the pioneering B.L.U.E (Blue Light User Exposure) Study, which demonstrated beneficial effects on ocular health and performance, sleep quality and eye strain and fatigue in those individuals with long duration exposure to digital screens and other sources of high-energy blue light.
The second session, Curcumin and Bioavailability with a Purpose, will take place from 16:00-16:25. Higher bioavailability isn’t enough anymore to make a formulation stand out — a multipronged, purposeful approach is required.
This session will discuss the latest trends and science in the bioavailable curcumin category to differentiate in a crowded marketplace, as well as the results of the FloMeD (Flow Mediated Dilation) Study, which showed that long-term supplementation with an optimal dose of curcuminoids from CurcuWIN Curcumin with Enhanced Absorption helped support healthy blood flow and circulation.
'We are eagerly looking forward to being a part of Hi Europe’s live events, which cater to the industry’s global health and nutrition leaders,' said Lynda M. Doyle, Sr VP of Global Marketing, OmniActive Health Technologies. 'Hi Europe is a strong forum to share our latest science, as well as what is driving the market and what is on the horizon.'
Through product-specific science and novel technologies, OmniActive is addressing the need for clinically supported, innovative branded ingredients head-on. In response to the overwhelming interest in OmniActive’s recent studies, all done in healthy populations, attendees are invited to booth G70 to further discuss both the FloMeD and B.L.U.E. studies, as well as
'OmniActive is excited to engage with our customers and share the latest scientific, clinical and market research on our entire product range at Hi Europe,' added Doyle. 'This year is marked with tremendous interest and market expanding opportunities arising from the exciting findings of our multiple human clinical studies.'
OmniActive will have market development managers and marketing specialists at booth G70 to provide custom solutions for the attendees’ most complex challenges.